Clinere Ear Wax Remover Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Bell Pharmaceuticals, Inc. is recalling 29,474 units of Clinere Carbamide Peroxide ear wax remover due to subpotent drug levels.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 9, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened
Bell Pharmaceuticals, Inc. initiated a voluntary recall of Clinere Carbamide Peroxide due to subpotent drug: low pH and significantly reduced assay (~0.6% vs expected ~6.7%).
Which Products Are Affected
The recall affects Clinere, Carbamide Peroxide products distributed nationwide in the United States. Affected items include a) 2 bottles of Clinere Carbamide Peroxide (2 x 0.50 mL) 6.5%, 0.5 fl. oz. (15 mL); b) 1 bottle of Clinere Carbamide Peroxide (0.50 fl. oz. (15 mL), Dist. by: Quest Products LLC, Pleasant Prairie, WI 53158, NDC 68229-102-01. Total quantity: 29,474 units. Lot numbers: a) 1504241, exp 2027-03; b) 1504291, 1504301, exp 2027-03. Recall number D-0679-2026. Classification: Class II.
What You Should Do
Consumers should refer to the FDA recall notice for further information on affected products.
Why This Matters
The recall involves a human OTC drug distributed across the U.S. due to reduced potency.
Source
https://www.fda.gov (Recall D-0679-2026, FDA)
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,011 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 9, 2026.
Frequently Asked Questions
Common questions about this FDA recall.